J107-0300 Screening compound: N-(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2H-1,3-benzodioxole-5-carboxamide

J107-0300 Screening compound: N-(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2H-1,3-benzodioxole-5-carboxamide
J107-0300 Screening compound: N-(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2H-1,3-benzodioxole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J107-0300
N-(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2H-1,3-benzodioxole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J107-0300

Molecular Formula

C20H17FN2O3 (C20 H17 FN2 O3)

Compound Name

N-(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2H-1,3-benzodioxole-5-carboxamide

IUPAC name

N-(6-fluoro-2349-tetrahydro-1H-carbazol-1-yl)-2H-13-benzodioxole-5-carboxamide

SMILES

O=C(c(cc1)cc2c1OCO2)NC(CCC1)c2c1c(cc(cc1)F)c1[nH]2

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

352.37

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.818

Distribution Coefficient, logD

3.818

Water Solubility, LogSw

-4.30

Polar Surface Area

51.821

Acid Dissociation Constant (pKa)

11.55

Base Dissociation Constant (pKb)

-3.05

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.00

J107-0300 in Drug Discovery

Included in Screening Libraries

Cardiovascular Library (22201 compounds)

DGK Inhibitors Library (10558 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with J107-0300 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J107-0300?
Check Price and Availability of J107-0300, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J107-0300 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J107-0300
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J107-0300
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J107-0300 available by request